CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes - Wikidata - awgldk - TriplyDB

CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes

CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes

http://www.wikidata.org/entity/Q24599841

about

Human polyomavirus reactivation: disease pathogenesis and treatment approaches Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain Progressive multifocal leukoencephalopathy: current treatment options and future perspectives Progressive multifocal leukoencephalopathy: clinical and molecular aspects Brincidofovir (CMX001) inhibits BK polyomavirus replication in primary human urothelial cells Differentiation of human fetal multipotential neural progenitor cells to astrocytes reveals susceptibility factors for JC virus.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy.The link between VLA-4 and JC virus reactivation.Highlights in antiviral drug research: antivirals at the horizon.The human JC polyomavirus (JCPyV): virological background and clinical implications.Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells.Effect of Leflunomide, Cidofovir and Ciprofloxacin on replication of BKPyV in a salivary gland in vitro culture system.Inter- and intralaboratory comparison of JC polyomavirus antibody testing using two different virus-like particle-based assays.Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA viruses.

P2860

Q21285083-74653630-C63C-405F-8912-5CFCCBCAE6EF Q24619923-2E68CD02-E7C3-4636-B9CF-07A234258262 Q26776236-3E24EEC1-B9E2-4CED-8467-5F1689DFEE98 Q26858968-958F2B18-8C67-4843-8814-9A789F859523 Q27324404-08662C64-C376-4F0A-81EC-749427CC1B48 Q30539642-7FA232DB-A58F-4F67-A628-D31525D9FCFD Q34212799-17C8FAAE-A704-4F7F-8EEE-6445B6FBD0D7 Q34801893-66C4E8FA-BE47-46B1-A57D-DF1AA2D0D31C Q37965603-143EBE59-170F-41EC-BBCB-62D38638E27F Q38007145-1727E476-DAC4-4F2A-9A55-548F4573E804 Q38115572-F714AD51-DD2F-4B12-B011-1CFB997E1641 Q38665891-B64A60F2-713D-4080-8ECB-007137F0DBDE Q38962966-451146B0-A767-4365-8FDD-B18020744FF1 Q39103226-0F16E733-B0E2-4E97-93D1-85409F513098 Q41727049-E725513B-B4F2-4987-9987-CCDAE4D5F6CD Q42200165-E4A70583-641A-4F12-93B4-1BE9F6468385

P2860

CMX001 (1-O-hexadecyloxypropyl-cidofovir) inhibits polyomavirus JC replication in human brain progenitor-derived astrocytes

http://www.wikidata.org/entity/Q24599841

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@ast

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@en

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@nl

type

label

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@ast

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@en

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@nl

prefLabel

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@ast

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@en

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@nl

P1433

Q24599841-1BBFEC70-12BE-4369-AD6A-A34FA768BDBF

P1476

Q24599841-108CEA54-EDD8-47A4-A601-D1B6A881AB38

P2093

Q24599841-00AEE8AB-C49D-42C1-AC5F-0F8C4F3A3613

Q24599841-62B59EEC-B694-44D2-BA4A-6DB33FD2E1A0

Q24599841-6F44A493-BE87-4ED0-92C1-E5E018BC57E5

Q24599841-93C25A71-0530-49BA-8BFC-69DFAF861F79

Q24599841-D987B5F6-D7EE-437A-82A8-EB1159022BBE

P2860

Q24599841-013A7BDF-62A2-4876-81D7-CDD045146190

Q24599841-14ED2A3F-AF44-4178-BD6A-3D1EA0A8C220

Q24599841-21A789B8-8769-4581-84E9-482E50437C87

Q24599841-2568D24C-8CB1-4A36-8DC7-0C104EE72081

Q24599841-298AC0E6-C331-47F9-BF77-7E4E799950D2

Q24599841-2F320C7B-017D-4BB8-BC61-F049D5D93E78

Q24599841-3BC9F39A-6687-45CB-9CBA-B6DA465B3C96

Q24599841-412E9A24-A99F-4A17-A1D9-B74D09945D93

Q24599841-45A42762-6C75-4863-B812-F5FE987D0403

Q24599841-4BC27EA9-7237-4E08-A68F-B21A1D676D74

P304

Q24599841-8AF96C2E-33C3-457E-8B22-041541E2318A

P31

Q24599841-8360E8F4-7B32-4DD8-8540-4EFF843D6D81

P356

Q24599841-E6714946-3ED4-4C41-BFD9-0D2FAABA5B7E

P407

Q24599841-4B5FF0B5-D0B3-4F06-A48C-9850F6A44D07

P433

Q24599841-7012BCF4-4956-4CCB-8DB2-72FCABFC697B

P478

Q24599841-A4FC9D35-DA93-4824-9949-CAD0EB5AE950

P577

Q24599841-EC164C0C-FA1E-46D6-B9BD-92CABD5CB3AF

P5875

Q24599841-F7A3E7EC-47CA-4F46-B140-3627BA1FFC02

P698

Q24599841-D2EC5D57-03FD-445C-A058-854F51F6AE4D

P921

Q24599841-4E7AFB91-A220-4677-9891-55AB2DEEF378

Q24599841-a4598d80-54c1-404a-b07d-645b61415423

P932

Q24599841-8087B1CA-0551-4F3C-95B3-59A1A161BD3B

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

CMX001 (1-O-hexadecyloxypropyl ...... progenitor-derived astrocytes

@en

P2093

Christine Hanssen Rinaldo

http://www.w3.org/2001/XMLSchema#string

Eugene O Major

http://www.w3.org/2001/XMLSchema#string

Hans H Hirsch

http://www.w3.org/2001/XMLSchema#string

Marion Wernli

http://www.w3.org/2001/XMLSchema#string

Rainer Gosert

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies

Activities of various compounds against murine and primate polyomaviruses

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.

Comparative activities of lipid esters of cidofovir and cyclic cidofovir against replication of herpesviruses in vitro.

Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases.

Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy.

P304

2129-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00046-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50395025

http://www.w3.org/2001/XMLSchema#string

P698

21402853

http://www.w3.org/2001/XMLSchema#string

P921

P932

3088264

http://www.w3.org/2001/XMLSchema#string